Back to Search
MICHAEL O ROACH MD
MD
Geriatric Medicine (Family Medicine) Physician
NPI: 1417970583Individual
Specialties, Licenses & Credentials
Geriatric Medicine (Family Medicine) PhysicianPrimary
Family Medicine — Geriatric Medicine
Code: 207QG0300X
G32190(CA)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
G32190(CA)
Research & Publications (20)
Predictive models in external beam radiotherapy for clinically localized prostate cancer.
PMID 19544539·Cancer·2009
6-review
Microarray analysis of developing flax hypocotyls identifies novel transcripts correlated with specific stages of phloem fibre differentiation.
PMID 18593690·Ann Bot·2008
8-other
Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610.
PMID 18172188·J Clin Oncol·2008
3-trial
Staging for prostate cancer: time to incorporate pretreatment prostate-specific antigen and Gleason score?
PMID 17167758·Cancer·2007
8-other
Racial differences in CYP3A4 genotype and survival among men treated on Radiation Therapy Oncology Group (RTOG) 9202: a phase III randomized trial.
PMID 17498886·Int J Radiat Oncol Biol Phys·2007
3-trial
Goserelin acetate in combination with radiotherapy for prostate cancer.
PMID 17257094·Expert Opin Pharmacother·2007
6-review
Microarray analysis of flax (Linum usitatissimum L.) stems identifies transcripts enriched in fibre-bearing phloem tissues.
PMID 17503083·Mol Genet Genomics·2007
8-other
Dose escalated external beam radiotherapy versus neoadjuvant androgen deprivation therapy and conventional dose external beam radiotherapy for clinically localized prostate cancer: do we need both?
PMID 18167004·Strahlenther Onkol·2007
4-observational
Base metal alloys used for dental restorations and implants.
PMID 17586146·Dent Clin North Am·2007
6-review
Defining high risk prostate cancer with risk groups and nomograms: implications for designing clinical trials.
PMID 17084158·J Urol·2006
8-other
Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial.
PMID 17011443·Int J Radiat Oncol Biol Phys·2006
2-rct
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.
PMID 16798415·Int J Radiat Oncol Biol Phys·2006
8-other
Radiotherapy plus adjuvant goserelin improves survival in men with poor prognosis prostate cancer.
PMID 16256275·Cancer Treat Rev·2005
8-other
Reducing the toxicity associated with the use of radiotherapy in men with localized prostate cancer.
PMID 15123413·Urol Clin North Am·2004
6-review
Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study.
PMID 15590164·Int J Radiat Oncol Biol Phys·2004
3-trial
Serum prostate-specific antigen and survival after external beam radiotherapy for carcinoma of the prostate.
PMID 12670556·Urology·2003
4-observational
Hormonal therapy and radiotherapy for localized prostate cancer: who, where and how long?
PMID 14610408·J Urol·2003
6-review
Race and survival of men treated for prostate cancer on radiation therapy oncology group phase III randomized trials.
PMID 12478146·J Urol·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 15625 IMPERIAL HWY
LA MIRADA, CA 90638 - Phone
- (562) 902-3000
Quick Facts
- NPI
- 1417970583
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile